Adam Morgan - Director at HERON THERAPEUTICS, INC. /DE/

Issuer-level insider activity

Role
Director
Issuer ticker
HRTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Adam Morgan since 14 Sep 2025

Reported holdings for Adam Morgan in HERON THERAPEUTICS, INC. /DE/

Form 4 holding Director

HERON THERAPEUTICS, INC. /DE/

Security class
Stock Option (Right to Buy)
Shares / value
35,900
Estimated value
$62,107
Report date
31 Jan 2025
Price
$1.73
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

HERON THERAPEUTICS, INC. /DE/

Security class
Series A Convertible Preferred Stock
Shares / value
70,012
Estimated value
Report date
08 Aug 2025
Price
Ownership
By Velan Capital Master Fund LP
Underlying class
Common Stock
Underlying amount

Transaction history for Adam Morgan in HERON THERAPEUTICS, INC. /DE/

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .